Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.

This publication has 36 references indexed in Scilit:

• A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 ?g ethinylestradiol and either 150 ?g desogestrel or 75 ?g gestodene
  The European Journal of Contraception & Reproductive Health Care, 1998
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Classification and comparison of oral contraceptives containing new generation progestogens
  Human Reproduction Update, 1995
• Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol
  Acta Obstetricia et Gynecologica Scandinavica, 1992
• Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent
  Acta Obstetricia et Gynecologica Scandinavica, 1992
• Comparative contraceptive efficacy and mechanism of action of the norgestimate‐containing triphasic oral contraceptive
  Acta Obstetricia et Gynecologica Scandinavica, 1992
• Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical Trials
  Acta Obstetricia et Gynecologica Scandinavica, 1990
• Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Desogestrel
  Acta Obstetricia et Gynecologica Scandinavica, 1988
• Oral contraceptives and venous thromboembolism: findings in a large prospective study.
  BMJ, 1986